ARTICLE | Clinical News
Actair regulatory update
March 31, 2017 5:17 AM UTC
Shionogi submitted a regulatory application in Japan for Actair house dust mite sublingual tablet to treat allergic rhinitis caused by house dust mites in patients ages 5-11. The sublingual immunother...